Top 15. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other top dividend ...

development and commercial milestones taking the potential value of the alliance to a maximum of $594 million. In both cases, the AI specialists will deliver small-molecule drugs to Merck for ...

Merck & Co's efforts to diversify its cancer ... watering $9.3 billion if all seven make it through to market and hit commercial objectives. The deal extends an earlier collaboration between ...

Merck Korea Managing Director Kim Woo-kyu, left and Merck Electronics Chief Commercial Officer Anand Nambiar pose for a photo at Semicon Korea 2025. [MERCK KOREA] Merck Electronics Chief ...

Merck Germany also confirmed that no legally ... SpringWorks Therapeutics’ first commercial product, Ogsiveo (nirogacestat), is a twice-daily oral medication that is the first and only FDA ...

Merck (NYSE:MRK) announced Tuesday that the ... Despite the approval, the company said Welireg's commercial launch in different EU states will depend on the timing of national reimbursements ...